Evaluation of efficacy and safety of Dermatitis Lotion in the treatment of Atopic Dermatitis in Children: A prospective, single center, interventional study

Amitojas Wellness Private Limited0 个研究点目标入组 0 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•1. Male and female children aged >= 6 months to <=12 years.
•2. Subject diagnosed with Atopic Dermatitis as per the medical judgement of the study investigator.
•3. Subject with mild to severe eczema as determined by the Patient-Oriented Eczema Measure (POEM) score.
•4. Children willing to provide informed assent if applicable.
•5. Childâ??s parent/guardian/legally acceptable representative willing to provide informed written consent.

•1. Children with significant medical/surgical condition which requires long-term treatment.
•2. Children with genetic diseases, congenital diseases and mentally challenged.
•3. Children who are currently being treated with other atopic dermatitis drugs.
•4. Subject has clinically infected atopic dermatitis at the time of screening.
•5. Allergy or sensitivity to any of the ingredients in the study treatment.
•6. Subjects who have participated in other clinical studies during the past 3 months or subjects who intend to participate in other clinical studies parallely.
•7. Subjects with any other illness or health condition which in the opinion/medical judgement of the study investigator makes the subject ineligible to participate in the study.

发起方